BioSpace News Archive

GRYT Health today announced the formation of its advisory board to provide strategic counsel as the Company continues to execute its business strategy.

Intensity Therapeutics, Inc. announced that a poster highlighting the safety profile, tumor regression activity and immune activation of the company’s lead product candidate, INT230-6, will be presented at the American Society of Clinical Oncology Annual Meeting, taking place May 31 to June 4, 2019 in Chicago.

Ingersoll Rand, Life365, STRATIS IoT, Leviton, and more to address connected health and energy management as adjacent ecosystems for the smart home at CONNECTIONS™

Percepta Professional™ for Physicians and Health Care Practitioners Contains Patented PTI-00703® Cat’s Claw and MemorTea®

Lifestyle Delivery Systems Inc.,, is pleased to announce that during its fourth quarter of 2018 the Company generated over three million dollars in revenue, as reported in its Annual Audited Financial Statements filed on SEDAR.

Placebell technology designed to limit the negative impact of the placebo effect in clinical trials

Actinium Pharmaceuticals, Inc. announced that an abstract pertaining to its lead product candidate, Iomab-B, which is being studied in the pivotal Phase 3 SIERRA study, will be presented via poster at the 2019 ASCO or American Society of Clinical Oncology Annual Meeting that is being held from May 31st – June 4th at McCormick Place, in Chicago.

New Category Offers Surgeons Strong, Secure Fixation and “Biologically Friendly” Approach to Restoring Patient Stability and Mobility with No Permanent Implant Left Behind

Company strengthens board of directors and scientific advisory board with appointments of Mike Raab and Benjamin Cravatt

Gastroenterology software provider collaborates with Change Healthcare and showcases mobile EHR features during Digestive Disease Week